What genetic conditions are linked to pancreatic ductal adenocarcinoma?
These rare genetic conditions can increase the risk of pancreatic cancer. Find out what to do if you have one of these genetic conditions.
Peutz-Jeghers syndrome
This causes lots of non-cancerous growths (polyps) in the digestive system, and dark spots on the hands and face. Nine out of ten cases (90%) are caused by a variant in a gene called STK11. This condition mainly increases the risk of bowel and breast cancer but may also increase the risk of pancreatic cancer.
The NICE guidelines for pancreatic cancer recommend monitoring for pancreatic cancer if you have Peutz-Jeghers syndrome.
BRCA2 and BRCA1 genes gene variants
Both men and women can have BRCA2 and BRCA1 gene variants. Variants in these genes greatly increase the risk of breast and ovarian cancer. They also increase the risk of other cancers, including prostate and skin cancer (melanoma).
There is some evidence that the BRCA2 gene variant can also increase the risk of pancreatic cancer.
Some families with the BRCA2 gene variant have more cases of breast and ovarian cancer. In these families, the risk of pancreatic cancer is only slightly increased.
In families with the BRCA2 gene variant but few cases of breast or ovarian cancer, the risk of pancreatic cancer is higher.
There’s less evidence that a variant in the BRCA1 gene increases the risk of pancreatic cancer.
The NICE guidelines recommend monitoring for pancreatic cancer if you have a variant in BRCA2 or BRCA1 and and a first degree relative (parent, brother, sister or child) with pancreatic cancer.
Most pancreatic, breast, ovarian, prostate and skin cancers aren’t caused by variants in BRCA2 or BRCA1. So if someone in your family has one of these cancers, it doesn’t mean you have a higher risk of developing one of them.
PALB2 gene variants
PALB2 is a gene linked to the BRCA2 gene. A variant in PALB2 increases the risk of breast cancer and slightly increases the risk of pancreatic cancer.
The NICE guidelines recommend monitoring for pancreatic cancer if you have a variant in PALB2 and a first degree relative with pancreatic cancer.
Familial atypical multiple mole and melanoma syndrome (FAMMM)
This is a condition caused by a variant in genes called CDKN2A (p16) and CDK4. People with FAMMM have large numbers of unusual moles. They also have a higher risk of skin cancer (melanoma) and pancreatic cancer.
The NICE guidelines recommend monitoring for pancreatic cancer if you have a variant in CDKN2A (p16) and a first degree relative with pancreatic cancer.
Lynch syndrome
Lynch syndrome is caused by variants in one of several genes – MLH1, MSH2, MSH6 or PMS2. Lynch syndrome increases the risk of bowel cancer. It also slightly increases the risk of some other cancers, including pancreatic cancer. You may hear of Lynch I or Lynch II. Lynch II is the form of the syndrome that may be linked with pancreatic cancer.
The NICE guidelines recommend that monitoring should be considered if you have Lynch syndrome and any first degree relatives with pancreatic cancer.
Lynch Syndrome UK supports people with the condition.
Li-Fraumeni syndrome
This is usually caused by a variant in a gene called TP53. It increases the risk of several cancers, including breast cancer, brain tumours and leukaemia (a type of blood cancer). It may also increase the risk of pancreatic cancer.